This announcement is a separate document:
Shekel Brainweight Ltd: SBW reports FY22 Q1 revenue growth of 22% on pcp (unaudited)
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.